SEINE BIO · PEPTIDE PROFILE

Afamelanotide

Pigmentation pathway · a specific light-sensitivity disorder

Approved product

Get to know the name, understand the evidence, and prepare a more informed conversation.

What is Afamelanotide?

Scenesse is an implant used to increase pain-free light exposure in adults with erythropoietic protoporphyria. It should not be confused with recreational tanning products or Melanotan II. Source & further reading.

THE FULL READING GUIDE · UPDATED OCTOBER 7, 2026

Inside the science of Afamelanotide.

Educational purpose only. Not medical advice. Consult licensed provider. Obtain from authorized compounding pharmacies only.

Compounding is available only where lawful for the specific substance and patient. Approved finished medicines may also be dispensed by licensed non-compounding pharmacies; this disclaimer does not establish access to any investigational product.

Overview

Afamelanotide is a melanocortin-1 receptor agonist available as the prescription implant Scenesse for adults with erythropoietic protoporphyria, or EPP. Its role concerns painful phototoxic reactions and light exposure in a rare disease. It is not interchangeable with melanotan II or an ordinary cosmetic tanning product.

Community Use

No exact afamelanotide profile from PeptideDosages or Peptidepedia was verified. The lack of a named community page does not justify importing an MT2 loading phase, injectable amount or tanning regimen. Different molecules, formulations and intended populations need their own evidence, particularly when an approved implant is involved.

Doses, Durations & Cycles

Published dosing regimens. Product-label and study regimens for education, not instructions for self-treatment. Product, indication and route matter.

Protocol reference — Afamelanotide
Route / formulation	Dose / reported phases	Frequency	Duration / break	Notes and source
Subcutaneous implant placed by a trained healthcare professional	16 mg implant	Every 2 months	Erythropoietic protoporphyria treatment Break: No informal tanning cycle established by this label	FDA prescribing information SCENESSE

Important context: The implant cannot be treated as interchangeable with an injectable powder.

Sources checked October 7, 2026. Educational listing does not establish prescribing approval or availability through Seine Bio.

The table reflects clinician-administered implant and study context. Scenesse’s label defines the product and scheduled care. An implant’s content cannot be converted into a consumer injectable cycle or a tanning-maintenance amount from this article.

Research Findings

Two randomized trials studied EPP and pain-free exposure to direct sunlight. They also assessed phototoxic reactions and quality of life. The trials answer a disease-specific question, not whether healthy individuals should use an implant to change appearance or increase recreational sun exposure.

U.S. Approval & Access

Scenesse is FDA-approved for its defined adult EPP indication. DailyMed lists DEA Schedule: None. That does not authorize self-implantation, an unapproved substitute or any other melanocortin product. Approval belongs to the finished medicine and labeled use, not a shared tanning-related mechanism.

What It Does in the Body

Melanocortin-1 receptor activity promotes pigment-related biology. The controlled-release implant has its own exposure profile; the label describes an approximately 15-hour apparent half-life. This does not establish an individual onset, peak protection or duration of benefit, and pigmentation is not a promise of unrestricted or risk-free sun exposure.

Benefits & Reported Experiences

The EPP trials found improvements in pain-free sunlight exposure and quality-of-life measures. Results should not be interpreted as a cosmetic tan guarantee or proof of universal photoprotection. A specialist plan should assess meaningful disease-related function while preserving appropriate light-protection measures and monitoring.

Side Effects & Risks

Label concerns include implant-site reactions, pigmentation changes, nausea and hypersensitivity. Existing and new pigmented skin lesions need appropriate examination. A treatment associated with pigmentation should not be assumed harmless simply because the visible outcome looks familiar; the patient’s rare disease and dermatologic context matter.

Delivery Options

The product is an implant administered by a trained healthcare professional. It is not a self-injection program, oral supplement or interchangeable research vial. This article supplies no implantation tutorial. Access and administration should be discussed with the qualified specialist responsible for the actual prescription product.

Product Quality & Storage

Scenesse’s label specifies refrigerated storage at 2–8°C and protection from light. These are instructions for the professional-use implant, not a shelf-life claim for other melanocortin materials. Confirm the authorized product and treating center rather than evaluating suitability from a marketplace photograph or purity statement.

Combinations & Interactions

An approved EPP implant does not establish a safe stack with MT2, other pigment-related substances or cosmetic products. Combination effects and exposure need their own assessment. There is no consumer combination schedule here, and shared receptor terminology should not be treated as permission to add another material.

Talking With Your Provider

If painful photosensitivity or EPP is a concern, a specialist can confirm the diagnosis and available care. If the goal is tanning or appearance, afamelanotide’s rare-disease evidence should not be repurposed into a promised solution. A clinician can help distinguish a cosmetic preference from symptoms that deserve diagnostic evaluation.

Educational purpose only. Not medical advice. Consult licensed provider. Obtain from authorized compounding pharmacies only.

Questions about what you read?
Explore the research library Create a free account
Educational information only. A free account lets you request review of your care goals. This profile does not establish availability, clinical suitability or access to the named compound.

Explore clinically appropriate options with a licensed provider. Inquiry does not guarantee a prescription, research-program acceptance or access to a particular substance.

Questions worth bringing to your appointment.

Are there alternatives that address my goal?
If treatment is appropriate, what monitoring and follow-up would I need?
Could my health history or current medicines change the risks?

A clinician may recommend a different option—or no medication—after assessing your individual circumstances.

Saved discussion topics 0

Save topics you would like to discuss with your healthcare provider. Saving is an expression of interest, not a treatment request or medical recommendation.

Saved only in this browser, on this device—not in a patient account. Other people using this browser may see your list. Clear it when using a shared device. This list is not sent to our team.

Bring your curiosity. Start a conversation.

Create a free account to request review and manage purchases. Paid membership is optional. Clinical review and authorization still apply where required, and any separate service charges are shown before you agree to pay.

Create a free account ↗

This educational information is free to read. Create a free account to request review of your care goals. Neither an account nor paid membership guarantees a prescription, access to the named compound or research enrollment.

Educational profile · U.S. context · October 7, 2026. This page does not provide personalized medical advice, dosing, or injection instructions.

Bring your saved topics to your care team.

Members can select up to five favorites and send a message for review. Your saved list stays in this browser until you choose what to submit.

Choose saved topics for review →